Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSaint John's Cancer Institute
About this trial
This is a prospective, registry study that will enroll all women with early stage breast cancer who will be treated with intraoperative radiotherapy (IORT) during breast-conserving surgery. The purpose of this study is to further validate the long-term effectiveness and safety of this treatment method. We aim to assess short and long-term patient outcomes associated with IORT, including perioperative complications, local and distance disease recurrences, as well as disease-free survival and overall survival.
Eligibility criteria
Qualifiers
Clinical stage Tis, T1, or T2(≤ 3cm), N0, M0 (AJCC Classification)
Unifocal Disease
Candidate for breast-conserving surgery
Recommended treatment by multidisciplinary team
Disqualifiers
Clinical stage T3-4, N1-3, M1
Multifocal disease
Trial design
Treatments tested in this trial
- Intraoperative Radiation Therapy (IORT)
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov